References
-
1
NIH conference .
diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement.
Ann Intern Med.
114
593-597
1990;
-
2
Burney R E, Jones K R, Christy B, Thompson N W.
Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels.
Surgery.
125
608-614
1999;
-
3
Chan A K, Duh Q Y, Katz M H, Siperstein A E, Clark O H.
Clinical manifestation of primary Hyperparathyroidism before and after parathyroidectomy.
Ann Surg.
222
402-413
1995;
-
4
Hasse C, Sitter H, Bachmann S, Zielke A, Koller M, Nies C, Lorenz W, Rothmund M.
How asymptomatic is asymptomatic primary hyperparathyroidism?.
Exp Clin Endocrinol Diabetes.
108
265-274
2000;
-
5
Hedbäck G, Odén A.
The increased risk of death of primary hyperparathyroidism - an update.
Europ J Clin Invest.
28
271-276
1998;
-
6
Leifsson B G, Ahren B.
Serum calcium and survival in a large health screening program.
J Clin Endocrinol Metab.
81
2149-2153
1996;
-
7
Lind L, Jacobson S, Palmer M, Lithell H, Wengle B, Ljunghall S.
Cardiovascular risk factors in primary hyperparathyroidism: a 15 year follow-up of operated and unoperated cases.
J Intern Med.
230
29-35
1991;
-
8
Palmer M, Bergstrom R, Akerstrom G, Adami H, Jakobsson S, Ljunghall S.
Survival and renal function in untreated hypercalcemia. Population-based cohort study with 14 years of follow-up.
Lancet.
O
59-62
1987;
-
9
Silverberg S J, Shane E, Jacobs T P, Siris E, Bilezikian J P.
A 10-year prospective study of primary hyperparathyroidism with and without parathyroid surgery.
N Engl J Med.
341
1249-1255
1999;
-
10
Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J, Niederle B.
Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up.
J Clin Endocrinol Metab.
82
106-112
1997;
Prof. Dr. F. Raue
Endokrinologische Gemeinschaftspraxis
Brückenstrasse 21
D-69120 Heidelberg
Telefon: +49-6221-43 90 90
Fax: +49-6221-43 90 99